Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations
Clinical trial NCT01206049 · COMPLETED
Trial details
- NCT number
- NCT01206049
- Sponsor
- Vejle Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2016-03-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.